Popular search terms:
Search Results
414 results found-
Global Product List
CSL Behring provides protein-based and recombinant therapies for bleeding disorders, immune deficiencies, hereditary angioedema and Alpha 1 antitrypsin deficiency, among others.
https://www.cslbehring.com/products/global-products-list -
Biotherapy Products | CSL Behring
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com/products -
Material Transfers
CSL Behring is committed to advancing scientific knowledge, fostering excellence, and supporting future medical researchers.
https://www.cslbehring.com/r-and-d/awards-and-grants/material-transfers -
Patents
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com/products/patents -
Watching Over Product Safety
Pathogen expert Nathan Roth leads a team that takes a vigilant approach with the medicines patients rely on.
https://www.cslbehring.com/vita/2019/pathogen-expert-nathan-roth -
Product Pipeline
CSL Behring is a global biotech leader in the development of new therapies for serious and rare disease.
https://www.cslbehring.com/r-and-d/product-pipeline -
Awards & Grants | CSL Behring
CSL Behring is committed to advancing scientific knowledge, fostering excellence, and supporting future medical researchers.
https://www.cslbehring.com/r-and-d/awards-and-grants -
Social Guidelines
Social Media Community Guidelines for CSL Behring Corporate Channels
https://www.cslbehring.com/social-guidelines -
PowerPoint Presentation
competitive developments affecting our products
https://www.cslbehring.com/-/media/shared/documents/7/rd-investor-briefing-2019.pdf -
Investigator-Initiated Studies
CSL Behring is committed to advancing scientific knowledge, fostering excellence, and supporting future medical researchers.
https://www.cslbehring.com/r-and-d/awards-and-grants/investigator-initiated-studies